Oct 20,2021

Microtech Medical raises $255M in Hong Kong debut amid glut of med-tech offerings

Microtech Medical (Hangzhou) Co. Ltd. raised around HK$1.98 billion (US$254.53 million) via its listing on the Hong Kong stock exchange, becoming the latest in a flood of med-tech companies listing in the city.

FUNDING IPO
View Analyst & Ambassador Comments
Go to original news
Oct 29,2021

Better Therapeutics Closes Business Combination and Debuts on Nasdaq

Better Therapeutics, Inc., a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the completion of its business combination with Mountain Crest Acquisition Corp II, a publicly traded special purpose acquisition corporation or SPAC. The transaction generated approximately $70 million in gross proceeds from the business combination, a private investment in a public equity from leading healthcare investors led by Farallon Capital Management, RS Investments, Sectoral Asset Management, and Monashee Investment Management, and the first tranche of a credit facility from Hercules Capital that was contingent on the closing of the business combination. The company has access to an additional $40 million from the Hercules Capital credit facility subject to certain milestones.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Nov 02,2021

Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin

Biolinq Incorporated, a medical device company developing a continuous glucose sensor with a novel integrated display on its wearable device, has announced the closing of a $100 million Series B financing round led by RiverVest Venture Partners. This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 12,2021

Tula Health Secures $8M from Investors

Tula Health received $8.3 million funding from the investors according to the SEC form registered.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 23,2021

Danish medtech startup Hedia raises €3 million and plans European expansion

Medtech startup from Copenhagen, Hedia, has just raised an additional €3 million for its technology to manage diabetes. The company is backed by Novo-heirs, and we reckoned it was one to watch back in 2019.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 31,2021

Onalabs opens an investment channel of 1 million euros in Capital Cell

Onalabs Inno-Hub, the biotechnology startup specialized in medical and sports monitoring devices, opens up to the entry of capital with an investment line of one million euros in the Capital Cell platform. With this, they will give a definitive boost to the development and commercialization of the HAD10 and L10 devices designed for the monitoring of chronic patients and athletes, respectively.

FUNDING EQUITY
View Analyst & Ambassador Comments
Go to original news
Dec 31,2021

PKvitality finalized its €6M Series A with a significant investment from EIC Fund

PKvitality, a French company specializing in bio-wearables, finalized a funding round of €6m, including an investment from the EIC Fund (European Innovation Council Fund). Other contributors to this round are Business Angels, EIT Health, alongside current investors on board, including Beurer GmbH.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 11,2022

Tula Health Raises $2.5 Million from Investors

Tula Health received $2.5 million funding from the investors according to the SEC form registered.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Feb 17,2022

Beta Bionics raises $57M to bring its artificial pancreas to the FDA

Shortly after wrapping up a pivotal trial of its device in Type 1 diabetes, Beta Bionics has secured $57 million to help complete the development of its fully automated artificial pancreas system and submit it to the FDA. The financing is a drop from the company’s most recent funding rounds, including a two-part series B that raised separate tranches of $63 million apiece across 2018 and 2019.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Feb 23,2022

Omada Health hits unicorn status with $192M Fidelity-led series E

Omada Health works in that white space, using data-driven personalized care to drive behavioral change. The company just banked $192 million in a series E funding round led by Fidelity, boosting its valuation to over $1 billion, the virtual chronic care management company confirmed to Fierce Healthcare. Fidelity led the series E round with participation from aMoon as well as existing investors Perceptive Advisors, Wellington Management, Civilization Ventures and others.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING